What is the GLOW blend?

GLOW combines GHK-Cu (50mg), BPC-157 (10mg), and Thymosin Beta-4 (10mg), three regenerative compounds targeting complementary pathways in tissue repair, collagen synthesis, and cellular regeneration.

Why combine these three peptides?

Each targets a different aspect of tissue repair: GHK-Cu addresses collagen and gene expression, BPC-157 promotes blood vessel formation, and TB-4 facilitates cell migration and tissue remodeling.

How should the GLOW blend be stored?

Store lyophilized powder below -18°C, away from light and moisture. Once reconstituted, refrigerate at 2–8°C and use within 7 days.

Why might the powder appear blue-green?

The GHK-Cu component contains a copper (II) ion complex that can give the powder a blue-green tint. This is normal and indicates the copper component is present.

Is the GLOW blend FDA approved?

No. None of the components are FDA approved as research peptides. This blend is sold for laboratory and research purposes only.

-16%

4X Tested - ISO 17025

98.17% View COA

Regenerative Blend

GLOW Blend

Certificate of Analysis

GLOW is a research blend combining GHK-Cu (50mg), BPC-157 (10mg), and Thymosin Beta-4 (10mg), three peptides studied for their roles in tissue repair, collagen synthesis, and cellular regeneration.

Size

Clear

BUNDLE & SAVE

1 Bottle $99.99 MOST POPULAR

2 Bottles $192.98

3+ Bottles $284.97

2-Day Shipping

Free Shipping
over $200

Free shipment
protection

Secure Checkout
256-bit SSL

Description

What is GLOW Blend?

The GLOW blend combines three well-studied regenerative compounds: GHK-Cu (Copper Tripeptide-1) at 50mg, BPC-157 (Body Protection Compound-157) at 10mg, and Thymosin Beta-4 (TB-4) at 10mg.

GHK-Cu is a naturally occurring copper-binding tripeptide studied for collagen synthesis, gene expression modulation, and antioxidant activity. BPC-157 is a gastric pentadecapeptide researched for tissue repair and angiogenesis. Thymosin Beta-4 is a 43-amino acid actin-regulating protein involved in cell migration and wound healing.

Together, these three compounds target complementary pathways: GHK-Cu addresses collagen and extracellular matrix remodeling, BPC-157 promotes blood vessel formation and growth factor signaling, and TB-4 facilitates cellular migration and tissue regeneration.

None of the components are approved by the FDA for therapeutic use as research peptides. This blend is sold strictly for laboratory and research purposes only.

Research Applications

Areas of Investigation

Skin & Tissue

Collagen & Matrix Remodeling

GHK-Cu stimulates collagen synthesis and extracellular matrix remodeling, complemented by BPC-157's growth factor signaling.

Healing

Multi-Pathway Tissue Repair

Combines three distinct mechanisms: copper-mediated gene modulation, angiogenesis, and actin-driven cell migration.

Recovery

Anti-Inflammatory Research

All three components have demonstrated anti-inflammatory properties through different pathways in preclinical models.

Regeneration

Regenerative Signaling

Studied for combined effects on growth factor expression, blood vessel formation, and cellular migration.

Compound Profile

Technical specifications

What is GLOW Blend?

Molecular Profile

Sequence

GHK-Cu: Gly-His-Lys (Cu²⁺) | BPC-157: GEPPPGKPADDAGLV | TB-4: Ac-SDKPDMAEIE KFDKSKLKKTETQEK NPLPSKETIE QEKQAGES

Molecular Formula

GHK-Cu: C₁₄H₂₃CuN₆O₄ | BPC-157: C₆₂H₉₈N₁₆O₂₂ | TB-4: C₂₁₂H₃₅₀N₅₆O₇₈S

Molecular Weight

GHK-Cu: 401.91 g/mol | BPC-157: 1,419.56 g/mol | TB-4: 4,963.44 g/mol

Appearance

Blue-green to white lyophilized powder

Form

Lyophilized (freeze-dried)

Handling & Shelf Life Guidelines

Storage & Stability

Storage (Pre-Reconstitution)

Store below -18°C, desiccated, away from light and moisture.

Storage (Post-Reconstitution)

Refrigerate at 2–8°C. For longer storage, aliquot and store below -18°C. Avoid freeze-thaw cycles.

Shelf Life

24 months from date of manufacture when stored as directed

Sensitivity Notes

Sensitive to heat, light, and moisture. Copper complex may affect pH. Keep sealed until use.

Compliance & Clinical Overview

Regulatory & Research Status

FDA Status

Not approved for human use. No component is FDA approved as a research peptide.

WADA Classification

BPC-157 and TB-4 are prohibited under class S0 (Non-Approved Substances). GHK-Cu is not listed.

Clinical Trial Status

All three components have extensive individual preclinical research. Combination studies are limited but suggest complementary mechanisms.

Published Studies

All three components have extensive individual preclinical research. Combination studies are limited but suggest complementary mechanisms.

Research Disclaimer

For laboratory and research purposes only. Not intended for human consumption.

COA's (Certificate of Analysis)

Third Party Tested by Freedom Diagnostics

98.17%

Purity

Variant

GLOW

Lot #

GL-2609-013

Labelled

70mg

Actual

71.61%

Tested

9/14/2026

View COA

(opens in a new tab)

99.81%